A signature of MM is cell cycle dysregulation characterised by over‐expression of cyclin D proteins along with reliance on anti‐apoptotic members of the BCL‐2 (B‐cell lymphoma‐2) family for survival [4]. Here, BCL2 is linked to Miyoshi myopathy.